|
Microorganism
|
Pilot study (n = 50)
|
Second part (n =100)
|
All patients (n =150)
|
|---|
|
Lp
|
C
|
Lp
|
C
|
Lp (G+)a
|
C (G+)a
|
|---|
|
Airway bacteria
| | | | | | |
| |
Oropharyngeal samples
|
1
|
0
|
1
|
1
|
2 (1)
|
2 (0)
|
|
Tracheal secretions
|
1
|
0
|
4
|
1
|
4 (2)
|
1 (0)
|
|
Staphylococci
| | | | | | |
| |
Oropharyngeal samples
|
1
|
0
|
6
|
6
|
7 (7)
|
4 (4)
|
|
Tracheal secretions
|
1
|
0
|
7
|
1
|
8 (8)
|
2 (2)
|
|
Enteric bacteria
| | | | | | |
| |
Oropharyngeal samples
|
8
|
13
|
22
|
16
|
31 (0)
|
29 (1)
|
|
Tracheal secretions
|
4
|
8
|
15
|
9
|
19 (1)
|
17 (1)
|
|
Fungi
| | | | | | |
| |
Oropharyngeal samples
|
6
|
8
|
8
|
14
|
14 (NA)
|
22 (NA)
|
|
Tracheal secretions
|
6
|
3
|
9
|
11
|
15 (NA)
|
14 (NA)
|
- Number of patients in whom new emerging bacteria or fungi were identified in oropharyngeal and tracheal secretions cultures. Two study parts and combined material separated
- Lp patients treated with Lactobacillus plantarum 299, C control patients treated with chlorhexidine, NA not available
- aNumber of patients with Gram-positive bacteria (G+) in respective groups presented in parentheses
